Publication Name	World Journal of Gastroenterology
Manuscript ID	1810
Country	China

Received	2013-01-08 16:05
Peer-Review Started	2013-01-08 18:26
To Make the First Decision	2013-02-01 21:34
Return for Revision	2013-02-05 18:23
Revised	2013-02-27 18:04
Second Decision	2013-03-28 17:25
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2013-03-29 11:56
Articles in Press
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2013-07-11 18:16
Publish the Manuscript Online	2013-07-29 11:18

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Genetics & Heredity
Manuscript Type	Autobiography
Article Title	Fibroblast growth factor receptor 4 Gly388Arg polymorphism in Chinese gastric cancer patients
Manuscript Source	Invited Manuscript
All Author List	Yan-Ying Shen, Ya-Chao Lu, Dan-Ping Shen, Yuan-Jie Liu, Xin-Ying Su, Guan-Shan Zhu, Xiao-Lu Yin and Xing-Zhi Ni
Funding Agency and Grant Number
Corresponding Author	Dr. Xing-Zhi Ni, Department of General Surgery, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, No. 1630 Dongfang Road, Shanghai 200127, China. niyin@yahoo.com
Key Words	Fibroblast growth factor receptor 4; Gly388Arg; Genetic susceptibility; Single nucleotide polymorphism; Gastric cancer
Core Tip	This study investigated the contribution of the fibroblast growth factor receptor 4 (FGFR4) Gly388Arg polymorphism as a genetic risk factor for gastric cancer (GC) and any associations between this polymorphism and clinicopathological parameters such as age, gender, clinical stage, tumor grade, human epidermal growth factor receptor 2 status and survival. The results suggested that the FGFR4 Gly388Arg polymorphism was not a risk factor for GC cancer initiation but that it was a useful prognostic marker for GC patients when the tumor was relatively small, well differentiated, or at an early clinical stage.
Publish Date	2013-07-29 11:18
Citation	Shen YY, Lu YC, Shen DP, Liu YJ, Su XY, Zhu GS, Yin XL, Ni XZ. Fibroblast growth factor receptor 4 Gly388Arg polymorphism in Chinese gastric cancer patients. World J Gastroenterol 2013; 19(28): 4568-4575
URL	http://www.wjgnet.com/1007-9327/full/v19/i28/4568.htm
DOI	http://dx.doi.org/10.3748/wjg.v19.i28.4568

Full Article (PDF)	WJG-19-4568.pdf
Manuscript File	1810-Review.doc
Answering Reviewers	1810-Answering reviewers.doc
Copyright License Agreement	1810-Copyright assignment.pdf
Non-Native Speakers of English Editing Certificate	1810-Language cetificate.pdf
Peer-review Report	1810-Peer review(s).pdf
Scientific Editor Work List	1810-Scientific editor work list.doc